Orbital Myositis after Herpes Zoster Ophthalmicus: A Case Report and a Narrative Review of the Literature
Pathogens · 2024
DOI: 10.3390/pathogens13100832 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pathogens, 2024. Verfasst von Edoardo Pace und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Internal Medicine, University of Turin, 10126 Turin, Italy. Hauptthemen laut MEDLINE: Antiviral Agents, Herpes Zoster Ophthalmicus, Orbital Myositis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Herpes zoster ophthalmicus results from the reactivation of the latent varicella zoster virus, affecting the first branch of the trigeminal nerve. In 20–70% of cases, Zoster Ophthalmicus can lead to ocular involvement, affecting various orbital structures. Orbital myositis is a rare but severe complication of herpes zoster ophthalmicus. We present a case of a 52-year-old man with no significant medical history who developed zoster-associated right ocular myositis and dacryocystitis. He was treated with intravenous acyclovir and oral steroids. A review of the literature identified 29 patients across 19 studies. The median age was 61 years, with a slight female predominance. In 55% of cases, the patients had no notable medical history. The most common presentation of myositis involved all oculomotor muscles. There were 22 cases who were treated with intravenous antiviral therapy and 19 received steroids. A full resolution of symptoms was achieved in 51.7% of patients. Zoster-related orbital myositis is a rare complication that should be considered even in immunocompetent individuals. It may occur either before or after the appearance of a vesicular rash. Magnetic resonance imaging is the preferred radiological exam for assessing orbital involvement. Intravenous antiviral therapy should be started within 72 h of symptom onset, and its combination with systemic corticosteroids appears to be an effective treatment for zoster-related ocular myositis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences, Internal Medicine, University of Turin, 10126 Turin, Italy.
- Department of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy.
- Unit of Infectious Disease 2U, University Hospital Città della Salute e della Scienza di Torino, 10100 Turin, Italy.
ORCID-Profile: Edoardo Pace, Tommaso Lupia, Maria Felice Brizzi, Francesco Giuseppe De Rosa
Zitieren
APA
Pace, E., Accardo, G., Lupia, T., Brizzi, M. F., Corcione, S., & De Rosa, F. G. (2024). Orbital Myositis after Herpes Zoster Ophthalmicus: A Case Report and a Narrative Review of the Literature. Pathogens. https://doi.org/10.3390/pathogens13100832
Vancouver
Pace E, Accardo G, Lupia T, Brizzi MF, Corcione S, De Rosa FG. Orbital Myositis after Herpes Zoster Ophthalmicus: A Case Report and a Narrative Review of the Literature. Pathogens. 2024. doi:10.3390/pathogens13100832
BibTeX
@article{Pace2024,
author = {Pace, Edoardo and Accardo, Guido and Lupia, Tommaso and Brizzi, Maria Felice and Corcione, Silvia and De Rosa, Francesco Giuseppe},
title = {Orbital Myositis after Herpes Zoster Ophthalmicus: A Case Report and a Narrative Review of the Literature},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13100832}
}
EUVIMED